Skip to main content
Log in

PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

(S)- and (R)-[11C]nicotine were synthesized by methylation of (S)- and (R)-nornicotine using [11C]methyl iodide. Following their intravenous injection in tracer doses to smoking and nonsmoking healthy males the radioactivity in arterial blood showed a sharp peak at about 1 min followed by a plateau level for the remaining 50 min of recording. Uptake in the brain, as measured by positron emission tomography (PET), was rapid with a peak at 5 min followed by a steady decline towards the end of the measurement. The regional distribution of radioactivity followed essentially the distribution of gray matter with high uptake in the cortex, the thalamus and the basal ganglia and low uptake in the pons, cerebellum and white matter. Levels of the labelled natural enantiomer, (S)-[11C]nicotine, were higher than those of the synthetic enantiomer, (R)-[11C]nicotine, particularly in the smokers. The time-activity curves of (S)-[11C]nicotine uptake were not changed by co-administration of 1.0 mg of unlabelled nicotine with the labelled nicotine. Similarly administration of unlabelled nicotine at the peak of radioactivity, 6 min following (S)-[11C]nicotine, had no effect on the time-activity curves. Thus essential criteria for visualizing receptor binding with the PET technique could not be fulfilled. Calculation of kinetic constants using a two-compartment model gave values indicating that the brain uptake of [11C]nicotine is mainly determined by the cerebral blood flow, extraction of the tracer over the blood-brain barrier and unspecific binding. Thus11C-labelled nicotine does not seem to be a suitable tracer for PET studies of nicotinic cholinergic receptors in the human brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bartus RT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417

    Google Scholar 

  • Benwell MEM, Balfour DJK, Anderson JM (1988) Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem 50:1243–1247

    Google Scholar 

  • Clarke PS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390–395

    Google Scholar 

  • Comar D, Mazièr M, Godot JM, Berger G, Soussaline F, Menini C, Arfel G, Naquet R (1979) Visualization of11C-flunitrazepam displacement in the brain of the live baboon. Nature 280:1184–1190

    Google Scholar 

  • Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190

    Google Scholar 

  • Curvall M, Kazemi Vala E, Engzell CR (1982) Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. J Chromatogr 232:283–293

    Google Scholar 

  • Deneris ES, Conolly J, Rogers SW, Duvoisin R (1991) Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci 12:34–40

    Google Scholar 

  • Farde L, Eriksson L, Blomqvist G, Halldin C (1989) Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET — a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696–708

    Google Scholar 

  • Ferris SH, DeLeon MJ, Wolf AP, Farkas T, Christman DR, Reisberg B, Fowler J, MacGregor R, Goldman A, George AE, Rampal S (1980) Positron emission tomography in the study of aging and senile dementia. Neurobiol Aging 1:127–131

    Google Scholar 

  • Flynn DD, Mash DC (1986) Characterization of L-(3H)nicotine binding in human cerebral cortex: Comparison between Alzheimer's disease and the normal. J Neurochem 47:1948–1954

    Google Scholar 

  • Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer's disease: Focal cortical changes shown by positron emission tomography. Neurology 33:961–965

    Google Scholar 

  • Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RLE, Carey JE, Wieland DM, Kuhl DE, Agranoff BW (1992) In vivo muscarinic cholinergic receptor imaging in human brain with [11C]-scopolamine and positron emission tomography. J Cereb Blood Flow Metab 12:147–154

    Google Scholar 

  • Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of Alzheimer type: positron emission tomography with [18F]-fluorodeoxyglucose. J Comput Assist Tomogr 7:590–598

    Google Scholar 

  • Jacob III P (1982) Resolution of (±)-5-bromonornicotine. Synthesis of (R)- and (S)-nornicotine of high enantiomeric purity. J Org Chem 47:4165–4167

    Google Scholar 

  • Halldin C, Någren K, Swahn C-G, Långström B, Nybäck H (1992) (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET. Nucl Med Biol 19:871–880

    Google Scholar 

  • Kuhl DE, Metter EJ, Riege WH, Hawkins RA (1985) Patterns of cerebral glucose utilization in dementia. In: Greitz T, Ingvar D, Widén L (eds) The metabolism of human brain studied with PET. Raven Press, New York, pp 419–430

    Google Scholar 

  • Långström B, Antoni G, Halldin C, Svärd H, Bergson G (1982) Synthesis of some11C-labelled alkaloids. Chem Scripta 20:46–48

    Google Scholar 

  • Larsson C, Nordberg A (1985) Comparative analysis of nicotine-like receptor-ligand interactions in rodent brain homogenate. J Neurochem 45:24–31

    Google Scholar 

  • Litton J, Bergström M, Eriksson L, Bohm C, Blomqvist G, Kesselberg M (1984) Performance study of the PC-384 positron camera system for emission tomography of the brain. J Comput Assist Tomogr 8:74–87

    Google Scholar 

  • Litton JE, Holte S, Eriksson L (1990) Evaluation of the Karolinska new positron camera system; the Scanditronix PC2048-15B. IEEE Transact Nucl Sci 37:743–748

    Google Scholar 

  • London ED, Waller SB, Wamsley JK (1985) Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett 53:179–184

    Google Scholar 

  • Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Therap 226:817–825

    Google Scholar 

  • Mazière M, Comar D, Marazano C, Berger G (1976) Nicotine-11C: Synthesis and distribution kinetics in animals. Eur J Nucl Med 1:255–258

    Google Scholar 

  • Nordberg A, Larsson, C (1980) Studies of muscarinic and nicotinic binding sites in brain. Acta Physiol Scand 479[Suppl]:19–23

    Google Scholar 

  • Nordberg A, Winblad B (1986) Reduced number of (3H)nicotine and (3H)-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115–119

    Google Scholar 

  • Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Andersson Y, Ulin, J, Winblad B, Långström B (1990) Decreased uptake and binding of11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm (P-D Sect) 2:215–224

    Google Scholar 

  • Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Ulin J, Andersson Y, Långström B, Winblad B (1991) Brain nicotinic receptor deficits in Alzheimer Patients as studied by positron emission tomography. In: Iqbal K, McLachlan DR, Winblad B, Wisniewski HM (eds) Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Wiley, Chichester New York Brisbane Toronto Singapore, pp 517–523

    Google Scholar 

  • Nybäck H, Nordberg A, Långström B, Halldin C, Hartvig P, Åhlin A, Swahn C-G, Sedvall G (1989) Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res 79:313–319

    Google Scholar 

  • Nybäck H, Nyman H, Blomqvist G, Sjögren I, Stone-Elander S (1991) Brain metabolism in Alzheimer's dementia: studies of11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiat 54:672–678

    Google Scholar 

  • Ohno K, Pettigrew KD, Rapoport SI (1979) Local cerebral blood flow in the conscious rat as measured with14C-antipyrine,14C-iodoantipyrine and3H-nicotine. Stroke 10:62–67

    Google Scholar 

  • Olson L, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alfauzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, Lundqvist H, Långström B, Meyerson B, Persson A, Viitanen M, Winblad B, Seiger Å (1992) Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm [P-D Sect] 4:79–95

    Google Scholar 

  • Persson A, Ehrin E, Eriksson L, Farde L, Hedström C-G, Litton J-E, Mindus P, Sedvall G (1985) Imaging of [11C]-labelled RO 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 19:609–622

    Google Scholar 

  • Romano C, Goldstein A (1980) Stereospecific nicotine receptors on rat brain membranes. Science 210:647–650

    Google Scholar 

  • Saji H, Magata Y, Yamada Y, Tajima K, Yonekura Y, Konishi J, Ohmomo Y, Yokoyama A (1992) Synthesis of (S)-N-[methy]-11C]nicotine and its regional distribution in mouse brain: A potential tracer for visualization of brain nicotinic receptors by positron emission tomography. Chem Pharm Bull 40:734–736

    Google Scholar 

  • Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic binding sites in the brain: regulation in vivo. Science 220:214–216

    Google Scholar 

  • Schwartz RD, McGee Jr R, Kellar KJ (1982) Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain. Mol Pharmacol 22:56–62

    Google Scholar 

  • Sedvall G, Farde L, Persson A, Wiesel F-A (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43:995–1005

    Google Scholar 

  • Steinbach JH, Ifune C (1989) How many kinds of nicotinic acetylcholine receptors are there? Trends Neurosci 12:3–6

    Google Scholar 

  • Wagner HN, Burns Jr HD, Dannals RF, Wong DF, Långström B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221:1264–1266

    Google Scholar 

  • Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146–151

    Google Scholar 

  • Wonnacott S, Russell MAH, Stolerman IP (1990) Nicotine psychopharmacology. Molecular, cellular and behavioural aspects. Oxford University Press, Oxford New York Tokyo

    Google Scholar 

  • Yamada S, Isogai M, Kagawa Y, Takayanagi N, Hayashi E, Tsuji K, Kosuge T (1985) Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin. Mol Pharmacol 28:120–127

    Google Scholar 

  • Yokoi F, Komiyama T, Ito T, Hayashi T, Iio M, Hara T (1993) Application of carbon-11 labelled nicotine in the measurement of human cerebral blood flow and other physiological parameters. Eur J Nucl Med 20:46–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nybäck, H., Halldin, C., Åhlin, A. et al. PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology 115, 31–36 (1994). https://doi.org/10.1007/BF02244748

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244748

Key words

Navigation